Daniella Beckman
CIK 1513422 · Chief Financial Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.71M
Companies
7
Total Filings
32
Lifetime Open-Market Net
-$198.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UPB | Director | — | $6.10 | — | $0 | 3 | 2026-06-11 |
| TNGX | Chief Financial Officer | 184,410 | $30.94 | $5.71M | -$198.7K | 8 | 2026-02-04 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 10,842 | $129.46 | $1.40M | $0 | 6 | 2025-07-21 |
| VOR | Director | — | $14.36 | — | $0 | 5 | 2025-05-23 |
| TBIO | Director | — | $0.00 | — | $0 | 4 | 2021-09-14 |
| 5:01 Acquisition Corp. (FVAM) Delisted | Director | — | $10.00 | — | $0 | 1 | 2020-10-20 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | SVP, CFO and Treasurer | — | — | — | $0 | 5 | 2014-08-05 |
Recent Filings · Page 3 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-14 | TBIO | Sell (S) | — | $0 | EDGAR |
| 2021-08-16 | TNGX | Grant (A) | — | $0 | EDGAR |
| 2021-06-16 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2021-02-09 | VOR | Grant (A) | — | $0 | EDGAR |
| 2020-10-20 | 5:01 Acquisition Corp. (FVAM) Delisted | Other (J) | — | $0 | EDGAR |
| 2020-06-17 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2019-06-19 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2014-08-05 | IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2014-02-12 | IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-02-22 | IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.